Over 5,200 of the world’s preeminent physicians, researchers, and industry leaders in aging intervention convened 12-15 December 2013 at The Venetian Resort & Exposition Center (Las Vegas, NV USA) to learn of the latest advancements in anti-aging and regenerative biomedical technologies. Representatives from more than 65 countries were in attendance, including health ministers and sports federation officials from China, Korea, Indonesia, Malaysia, and Brazil.
Slideshow: Highlights of the A4M Winter 2013 Congress
Navigate by clicking on the “Previous Slide” and “Next Slide” text in the gray strip below.
 A4M President Dr. Ronald Klatz |
“After 22 years, anti-aging medicine is now the leading buzzword in biomedical technologies. Anti-aging medical biotechnologies save countless lives and increases both lifespans and healthspans,” says Dr. Ronald Klatz, President of the American Academy of Anti-Aging Medicine (A4M; www.worldhealth.net & www.a4m.com).
“Preceding the establishment of A4M in 1991, the global anti-aging market stood at zero dollars. Valued at $250 billion in 2012, and projected to grow at a compound annual growth rate of 5.7%, analysts at BCC Resea rch expect the industry to top $345 billion in 2018,” observes A4M Chairman Dr. Robert Goldman. |
 A4M Chairman Dr. Robert Goldman |
